Press release
Asthma and Allergy Incidence Drive Leukotriene Modifiers Market to Grow from $21.04B in 2023 to $28.48B by 2028 at 6.3% CAGR, New Report Reveals
Leukotriene Modifiers Market Report
As per the report, the leukotriene modifiers market size has grown strongly in recent years. It will grow from $21.04 billion in 2023 to $22.33 billion in 2024 at a compound annual growth rate (CAGR) of 6.1%. The leukotriene modifiers market size is expected to see strong growth in the next few years. It will grow to $28.48 billion in 2028 at a compound annual growth rate (CAGR) of 6.3%.
Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=16109&type=smp
The Rising Incidence Of Asthma And Allergic Conditions Drives Growth In The Leukotriene Modifier Market
The rising incidence of asthma and allergic conditions is expected to propel the growth of the leukotriene modifier market going forward. Asthma and allergic conditions refer to a group of disorders characterized by hypersensitivity reactions of the immune system to various allergens, resulting in inflammation and other symptoms. The increasing incidence of asthma and allergic conditions can be attributed to increased exposure to pollutants, rising temperatures, changing weather patterns, and higher population density. Leukotriene modifiers help manage and alleviate symptoms of asthma and allergic conditions while also improving overall respiratory function, reducing inflammation, and providing a safer and more effective treatment option for patients with chronic respiratory issues. For instance, in May 2024, according to the data published by the National Center for Health Statistics (NCHS), a U.S.-based health statistics agency, the prevalence of current asthma among adults aged 18 and over in the United States increased from 8.4% in 2021 to 8.7% in 2022. Additionally, the incidence of asthma episodes in the past 12 months for adults in the same age group rose from 3.3% in 2021 to 3.7% in 2022. Therefore, a rising incidence of asthma and allergic conditions is driving the leukotriene modifier market.
Expansion Of Leukotriene Modifiers Market With Generic And Extended-Release Formulations Boosts Asthma Management
Major companies operating in the leukotriene modifier market are focusing on developing generic formulations, such as extended-release (ER) tablets, to expand their portfolios and cater to the growing demand for more convenient and effective treatments. Generic extended-release (ER) tablets are pharmaceutical formulations of medications designed to release their active ingredients gradually over an extended period, typically offering convenience and improved dosing schedules compared to immediate-release formulations. For instance, in April 2023, Camber Pharmaceuticals Inc., a US-based pharmaceutical company, added Zileuton ER Tablets to its portfolio. These tablets are indicated for the prophylaxis and chronic treatment of asthma in adults and children aged 12 years and older. The tablets are not intended for the reversal of bronchospasm in acute asthma attacks but can be continued during acute exacerbations of asthma. Zileuton ER Tablets are available in 600 mg strength in 120-count bottles.
The leukotriene modifiers market covered in this report is segmented -
1) By Drug Type: Montelukast, Zafirlukast, Zileuton ER, Zileuton
2) By Form: Tablets, Chewable Tablets, Oral Granules
3) By Distribution Channel: Hospitals Pharmacies, Retail Pharmacies, Drug Stores, Online Pharmacies
Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=16109&type=discount
Major companies operating in the leukotriene modifiers market are Merck And Co., Sanofi SA, AstraZeneca PLC, Novartis AG, GlaxoSmithKline plc, Boehringer Ingelheim International GmbH, Viatris Inc., Teva Pharmaceutical Industries Ltd., Hetero Drugs Limited, Sun Pharmaceutical Industries, Sumitomo Dainippon Pharma, Chiesi Farmaceutici S.p.A., Cipla Limited, Aurobindo Pharma Limited, Dr. Reddy's Laboratories, Apotex Pharmaceutical Holdings Inc., Torrent Pharmaceuticals Ltd., DAVA Pharmaceuticals, Alembic Pharmaceuticals Ltd., Starallergens Greer Ltd, Lannett Company, Accord Healthcare, Jubilant Life Sciences Ltd., Aytu BioScience, Annett Company Inc.
Contents of the report:
1. Executive Summary
2. Leukotriene Modifiers Market Report Structure
3. Leukotriene Modifiers Market Trends And Strategies
4. Leukotriene Modifiers Market - Macro Economic Scenario
5. Leukotriene Modifiers Market Size And Growth
…..
27. Leukotriene Modifiers Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Explore the report store to make a direct purchase of the report @ https://www.thebusinessresearchcompany.com/report/leukotriene-modifiers-global-market-report
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Asthma and Allergy Incidence Drive Leukotriene Modifiers Market to Grow from $21.04B in 2023 to $28.48B by 2028 at 6.3% CAGR, New Report Reveals here
News-ID: 3586229 • Views: …
More Releases from The Business Research Company
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future.
Market Valuation and Expansion Forecast for Personalized Testing…
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry.
Projected Expansion in the Skin…
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory.
Steady Growth Expected in Upadacitinib Market Size Through 2029
The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual…
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field.
Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics…
More Releases for Leukotriene
The Rising Incidence Of Asthma And Allergic Conditions Drives Growth In The Leuk …
"Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
How Large Will the Leukotriene Modifiers Market Size By 2025?
In the past few years, the leukotriene modifiers market has seen a significant increase in size. The market is projected to expand from $22.33 billion in 2024 to $23.54 billion in 2025, reflecting a compound annual growth rate (CAGR)…
The Rising Incidence Of Asthma And Allergic Conditions Drives Growth In The Leuk …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.
What Will the Leukotriene Modifiers Industry Market Size Be by 2025?
The market for leukotriene modifiers has seen vigorous growth in past years. Predictions show an increase from a valuation of $22.33 billion in 2024 to approximately $23.77 billion in 2025, with a compound annual growth rate (CAGR) of…
Leukotriene Inhibitors Market Future Business Scope Analysis Report, Marketing S …
" The leukotriene inhibitors market is poised for substantial growth, with an estimated value of approximately $5.2 billion in 2024. Projections indicate that the market could reach around $8.8 billion by 2034, reflecting a Compound Annual Growth Rate (CAGR) of about 5.3% over the 2025-2034 forecast period. "
Exactitude Consultancy., Ltd. released a research report titled "Leukotriene Inhibitors Market". This report covers the global Leukotriene Inhibitors market sales, sales volume, price,…
Leukotriene Inhibitors Market : An Detailed Overview
Introduction:
Leukotriene inhibitors are medications used to manage and treat conditions such as asthma and allergic rhinitis. These drugs work by blocking the action of leukotrienes, which are inflammatory molecules that contribute to bronchoconstriction, mucus production, and airway inflammation. Leukotriene inhibitors, including montelukast, zafirlukast, and pranlukast, are widely used due to their effectiveness in reducing asthma symptoms and improving respiratory function. The market is expanding as respiratory diseases become more prevalent,…
Leukotriene Modifiers Market Analysis, Industry Size, Share, Key Players And For …
The Business Research Company recently released a comprehensive report on the Global Leukotriene Modifiers Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample…
Leukotriene A 4 Hydrolase Market to see Rapid Growth by 2031
The Leukotriene A 4 Hydrolase Market size is expected to grow at an annual average of CAGR 2% during the forecast period (2024-2031). Leukotriene A4 hydrolase (LTA4H) is an enzyme that plays a crucial role in the inflammatory response by participating in the metabolism of leukotrienes, which are lipid compounds involved in mediating inflammation and immune responses
Leukotriene A 4 Hydrolase Market research report is one of the effective ways to…
